Downloaded 13 times
Anti Counterfeiting Americas (2010)
- 1. Anti-Counterfeiting Americas Maintaining patient safety and securing the supply chain 8th – 9th November 2010, Boston, USA BOOK NOW! Key Speakers Scott LaGanga, Executive Director, Partnership for Safe Medicines Lorne M Lipkus, Partner, Kestenberg Siegal Lipkus LLP Robert Celeste, Director, Healthcare, GS1 US Andres Diaz Cote, President, Figurazione Steve Wood, President & CEO, Covectra Sharon Flank, CEO, InfraTrac Philip Payne, Investigative Partner, RSSL Jim Williams, Founder & Chief Scientist, Polyonics Media Partners Organised By Driving the Industry Forward | www.futurepharmaus.com To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/anti-counterfeiting
- 2. Conference Introduction Anti-Counterfeiting Americas 8th - 9th November 2010, Boston, USA Dear Colleague, Media Partners: ncreasing efforts are being made to protect the national supply chain for medicines I PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical distribution. In the US, the pharmaceutical supply chain involves the daily delivery of sector. Supported by most of the leading pharmaceutical corporations, approximately 13 million prescription products to pharmacies, hospitals, clinics and other PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry healthcare provider locations (Source: Urch Publishing, July 2009). professionals across Europe and the US. isiongain’s Anti-Counterfeiting Americas conference will provide valuable insights, into V For further information please email: corporate@pharmiweb.com the latest issues and track and trace packaging technologies shaping the fields of security BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and and supply chain management, with leading experts presenting the best-practices on located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide tackling pharmaceutical counterfeiting and fraud, improving the integrity of distribution the world’s biotech and pharma information and market to make it universally accessible and useful for channels and relationships between key parties. scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY y attending the Anti-Counterfeiting Americas conference delegates will gain a B EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of comprehensive understanding of this rapidly changing sector, from the complex structure the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to of the supply chain, to the growth in mail order and online pharmacies. The potential for investment in the pharmaceutical logistics market remains high. The FDA has put global biotechnology, pharmaceutical and life science activities. additional focus on “corporate responsibility” for supply-chain management, and For further information please visit www.biotechnology-europe.com increased vigilance and action is needed due to the rise of counterfeit drugs in the global Future Pharmaceuticals has forged powerful relationships with key industry Driving the Industry Forward | www.futurepharmaus.com supply chain. Anti-counterfeiting initiatives discussed include the use of technology- leaders to provide a platform for successful brand recognition, and for senior based measures, repackaging, consumer education, and increased collaboration with domestic and international law enforcement agencies. decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, By attending this conference you will: specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a • Measure the impact of counterfeit drugs by using a patient centric approach highly targeted and responsive audience, bridging the gap between the industries’ top issues and the • nderstand the development process necessary to ensure an effective security U solutions top-tier vendors can provide. strategy For further information please visit: www.futurepharmaus.com • Improve inventory control InPharm is the online platform for exclusive pharmaceutical news, comment, • Hear changes in the US FDA and European policies • evelop global standards to increase patient safety and elevate supply chain D contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile integrity and Pharmafocus. • Learn about leveraging supplier audits throughout a global organization For further information please visit: www.In-Pharm.com • nderstand the challenges of the global traceability and serialization regulatory U Pharma Connections Worldwide® is the leading professional business environment networking website focused in the Pharmaceutical, Biotechnology and Life • Utilize auto-ID advancements in packaging technologies Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled • Hear the latest strategies for defending your brand and pursuing offenders with the right clientele in order to facilitate business development opportunities among industry • Develop working relationships with US law enforcement authorities professionals responsible for making key decisions in a global marketplace. • alance the need for tamper-proof packaging with streamlining your supply chain B • Evaluate current methods for the detection of counterfeit medicines For further information please visit: www.pharmaconnections.com • Be part of a unique networking opportunity The Partnership for Safe Medicines is a coalition of more than 50 patient, physician, pharmacist, university, industry and other professional organizations I look forward to meeting you at the conference around the world committed to the safety of prescription drugs and protecting consumers against Best regards unapproved, counterfeit, substandard, mishandled or otherwise unsafe medicines. For further information please visit: www.safemedicines.org/ Maninder Paul Conference Producer Sponsorship and exhibition opportunities: Target Audience: This event offers a unique opportunity to meet and do business with some • Pharmaceutical manufacturing and distributing companies • Drug wholesalers of the key players in the pharmaceutical and biotech industries. If you have • Public health and regulatory bodies • Legal firms a service or product to promote, you can do so at this event by: • Customs and border agencies • Pharmaceutical packaging and labelling companies • Hosting a networking drinks reception • Anti-counterfeiting technology and service suppliers • Pharmaceutical specialist couriers • Taking an exhibition space at the conference • Anti-counterfeiting organizations • Contract manufacturing organizations (CMOs) • Advertising in the delegate documentation pack • Retail pharmacy chains • Non-governmental healthcare organizations and Academia • Providing branded bags, pens, gifts, etc. Who should attend: If you would like more information on the range of sponsorship or exhibition Chief Security Officers, VPs, directors, heads, managers and specialists of: • upply chain/ Supply Chain Security/ Supply Chain Systems/ Global Supply Chain S possibilities for visiongain's Pharmaceutical Anti-counterfeiting Americas • Anti-counterfeit Projects / Anti-counterfeiting Operations • Distribution/ Logistics Conference, please contact us: • Security/ Global Security • Packaging & Labelling Ronald Reyes Magali: +44 (0)20 7549 9934 • Brand Protection • Legal Counsel ronald.magali@visiongainglobal.com • Regulatory Affairs/ Intellectual Property • Quality Assurance/ Quality Control John Changkarn: +44 207 549 9968 • Compliance • Information systems john.changkarn@visiongainglobal.com • Information system
- 3. Day 1 Anti-Counterfeiting Americas Monday 8th November 2010 09:00 Registration and refreshments 12:00 Counterfeiting in developing countries: The use of mixed technology 09:30 Opening address from the chair • xternal control in massive consume products E • he ‘umbrella brand’ concept: The perfect attack T orne M Lipkus L Partner • nternal control in massive consumer products I Kestenberg Siegal Lipkus LLP • he colombia case T • esults and real benefits R 09:40 The business value of product serialization within ndres Diaz Cote A the pharmaceutical supply chain President Figurazione A cross the U.S. pharmaceutical supply chain, organizations are aligning themselves to enable more effective product serialization and increased visibility using new standards. With widespread serialization comes 12:40 Networking lunch tremendous opportunity for pharmaceutical manufactures and their trading partners to leverage new standards for increased efficiency and greater ROI. 13:40 Protecting IP rights In this session, the GS1 Healthcare US organization, the US implementation • rademarks and identity preservation T arm of the leading standards-setting body for product identification, • istory of branding and quality assurance H illustrates the business value of serialization and pedigree/visibility • auses of counterfeiting C information. • nti-counterfeiting technology and choice A • GS1 EPCIS standard as a pathway to significant potential business value • The status of adoption of GLN and GTIN in pharma 14:20 Track and Trace at the WIP manufacturing level • verview for analyzing tradeoffs between brand protection technologies O • The industry status for using serial data to match product • hy is information regarding authentication of products and their W • How serialization can provide enormous visibility into the supply chain movement critical? • pdate on the 2015 readiness program (preparing for serialization and U • Pre-adaption” of pharmaceutical manufacturers to incorporate brand “ pedigree within the US) authentication as an integral part of their existing operations obert Celeste R im Williams J Director, Healthcare Founder & Chief Scientist GS1 US Polyonics 10:20 Forging strategic partnerships to elevate 15:00 Afternoon refreshments product integrity 15:20 Illegal internet pharmacies: A framework for • ndustry trends I coordinated action and cooperation • eveloping and applying a risk management process D • llegal internet pharmacies: Extent of the problem I • ction against illegal internet pharmacies: What has been done? A • ssessing qualifications A • hat remains to be done: The need for additional action W • ransitioning a qualified vendor into a strategic partner T • ase study C 16:00 Supporting safe medicines strategies in developing countries ike Lewis M Business Development Manager • hich developed countries are the most susceptible destination markets W Sentry BioPharma Services for counterfeit drugs? • ssessing the scale and economic cost of counterfeiting A 11:00 Morning refreshments • iscuss the role of drug regulations and law enforcement D • ooperation with national & international agencies C 11:20 Securing pharmaceuticals against counterfeiting: om Woods T Assessing latest protection technologies President Woods International • atest developments in anti-counterfeiting technologies L • ackaged-bases vs on-product solutions P 16:40 Closing remarks from the chair • esigning a comprehensive anti-counterfeiting strategy D rank Schurgers F Managing Director 16:50 Networking drinks Integris Take your discussions further and build new relationships in a relaxed and informal setting. Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2010
- 4. Day 2 Anti-Counterfeiting Americas Tuesday 9th November 2010 09:00 Registration and refreshments 13:40 Detecting pharmaceutical counterfeiting • Stages of investigation • Investigation and detection of contamination in pharmaceutical products 09:30 Opening address from the chair • QC and GMP techniques hilip Payne P 09:40 Cost-effective anti-counterfeiting solutions for the Investigative Partner second tier RSSL • Repackaging and counterfeiting • Technologies 14:20 Case study: Utilizing forensic analysis in support of • valuate packaging-based and product-based anti-counterfeiting E counterfeit investigations measures by cost, complexity, and effectiveness for second tier products T he presentation will look at various strategies to utilize forensic evidence haron Flank S for carrying out counterfeit investigations CEO aughn Volpi V InfraTrac President PICA 10:20 Protecting medicines from diversion and counterfeiting 15:00 Afternoon refreshments • A multi-layered approach for brand protection • Specialty distribution as a tool for combating diversion 15:20 The global impact of fake medicine • sing smartphones and mobile phones in brand integrity and U loyalty programs • Overview of the counterfeit drugs: Some examples teve Wood S • How fake medicines harm patients and public President & CEO • Building a Coalition: A call to action Covectra cott LaGanga S Executive Director Partnership for Safe Medicines 11:00 Morning refreshments 16.00 Protecting profits and patient safety through 11:20 Combating pharmaceutical anti-counterfeiting from implementing new technologies a legal perspective • Preventative technologies • Relationship between parallel trade and counterfeiting • Authentication technologies • Basic framework for the parallel trade of pharmaceuticals • Track & Trace technologies • Recent and future developments 16:40 Chair’s closing remarks 12:00 Balancing the need for tamper-proof packaging with streamlining your supply chain • Cost to manufacturers 16:50 End of conference • Choosing the right tamper-evident packaging for your product • The smarter supply chain of the future 12:40 Networking lunch
- 5. Registration Form Anti-Counterfeiting Americas 8th - 9th November 2010, Boston, USA For multiple bookings Photocopy this form Conf. code VG Anti-Counterfeiting Standard Prices Conference only Fee: £1299 (USD 1892*) Americas *USD price is estimate only 8th - 9th November 2010 Promotional Literature Distribution Distribution of your company’s promotional literature to all conference attendees Boston, USA Fee: £999 VAT: £174.83 Total: £1173.83 Details How to book Forename: Surname: Email: conferences@visiongainglobal.com Web: http://www.visiongain.com/anti-counterfeiting Job Title: Company: UK Office: Tel: +44(0) 20 7336 6100 Main Switchboard Number: Fax: +44(0) 20 7549 9932 Visiongain Ltd Address: BSG House 226-236 City Road London EC1V 2QY Country: Postcode: UK General information Phone: Fax: Venue: TBA Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Email: Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the Signature: right to charge interest on unpaid invoices. Substitutions/name changes or cancellations: There is a 50% liability on all bookings once I confirm that I have read and agree to the terms and conditions of booking made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable Methods of payment to transfer places between conferences and executive briefings. However, if you cannot attend the Payment must be made in sterling conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or By Mail: Complete and return your signed registration form together with your cheque payable organisation and are not transferable between countries. to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the By Fax: Complete and fax your signed registration form with your credit card details customer by credit card prior to the changes being made. to +44 (0) 20 7549 9932 Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or By Bank Transfer: cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. Visiongain Ltd A/C: visiongain Ltd Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data Barclays Bank Sort Code: 20-71-64 Protection Act 1988. Your personal information contained in this form may be used to update you on Piccadilly Branch Account No: 6038 7118 visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We 48 Regent Street Swift Code: BARC GB22 may also share your data with external companies offering complementary products or services. If you wish for your details to be amended, suppressed or not passed on to any external third party, please London, W1B 5RA IBAN: GB80 BARC 20716460387118 send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. Please debit my credit card: Please allow approximately 30 days for your removal or update request to be applied to our database. Access MasterCard Visa American Express Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Card number: This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Expiry Date: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT. Security number (last 3 digits on back of credit card): How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Signature: Unable to attend Obviously nothing compares to being there but you need not miss out. Simply tick the box and send Cardholder’s name: with your payment. You will receive your copy of the event CD Rom two weeks after the event. Yes, please send me a copy of the CD for Price£550 VAT:£96.25 Total:£646.25 News updates Office use only Please tick if you do not want to receive email news updates in the future www.visiongain.com/anti-counterfeiting